| Dr Phyllis Chang, MD | |
|
604 5th St, Coralville, IA 52241-2304 | |
| (319) 358-8788 | |
| (319) 351-9278 |
| Full Name | Dr Phyllis Chang |
|---|---|
| Gender | Female |
| Speciality | Plastic Surgery - Surgery Of The Hand |
| Location | 604 5th St, Coralville, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407922768 | NPI | - | NPPES |
| 1273599 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2082S0105X | Plastic Surgery - Surgery Of The Hand | 26997 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Phyllis Chang, MD 604 5th St, Po Box 5036, Coralville, IA 52241-2304 Ph: (319) 358-8788 | Dr Phyllis Chang, MD 604 5th St, Coralville, IA 52241-2304 Ph: (319) 358-8788 |
News Archive
The Parkinson's Progression Markers Initiative, a landmark biomarker clinical study, has completed enrollment of its initial 600-member cohort of Parkinson's patients and controls, and will launch additional study cohorts to leverage the existing PPMI infrastructure and evaluate multiple potential biomarkers for Parkinson's disease.
Hearing loss has been linked with a variety of medical, social and cognitive ills, including dementia. However, a new study led by a Johns Hopkins researcher suggests that hearing loss may also be a risk factor for another huge public health problem: falls.
BRAF mutation occurs in between 40% and 50% of metastasising melanomas (skin cancers), boosting tumour growth.
This September, the Prostate Conditions Education Council reminds men to set aside 10 minutes to take lifesaving measures. In just 10 minutes, the same amount of time it takes to shave their faces, men can be screened for prostate cancer, the second leading cause of death among American men. For one week this month the Prostate Conditions Education Council (PCEC) will be coordinating Prostate Cancer Awareness Week (PCAW), which provides free or low-cost screenings to thousands of men across the United States.
DATATRAK International, Inc., the leader in developing cloud-based, unified eClinical technologies and delivering related services for the clinical trials industry, today announced three CRO Enterprise Partners have expanded their agreements. These industry-leading organizations have chosen to boost their global licensing capacity and extended their relationship with DATATRAK.
› Verified 2 days ago